Clinical pharmacology of ticarcillin in the newborn infant: Relation to age, gestational age, and weight

John D. Nelson, Sharon Shelton, Helen Kusmiesz

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Ticarcillin, a new penicillin derivative with greater in vitro activity against Pseudomonas than carbenicillin, was given as a single dose of 50 mg/kg intramuscularly on 61 occasions to 54 neonates and young infants. The serum concentrations and rate of elimination varied considerably depending upon gestational age, chronological age, and body weight. Peak serum concentrations depended principally upon the volume of distribution which approximated the extracellular fluid volume of the neonate. The plasma clearance and serum half-life of the drug were determined. From these pharmacokinetic data appropriate groupings according to age and body weight were made and dosages and intervals of administration predicted for clinical trials of efficacy with repeated doses.

Original languageEnglish (US)
Pages (from-to)474-479
Number of pages6
JournalThe Journal of Pediatrics
Volume87
Issue number3
DOIs
StatePublished - 1975

Fingerprint

Ticarcillin
Clinical Pharmacology
Gestational Age
Newborn Infant
Weights and Measures
Serum
Body Weight
Carbenicillin
Extracellular Fluid
Pseudomonas
Penicillins
Half-Life
Pharmacokinetics
Clinical Trials
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Clinical pharmacology of ticarcillin in the newborn infant : Relation to age, gestational age, and weight. / Nelson, John D.; Shelton, Sharon; Kusmiesz, Helen.

In: The Journal of Pediatrics, Vol. 87, No. 3, 1975, p. 474-479.

Research output: Contribution to journalArticle

@article{ab0ac99a82eb40499c842694f7052152,
title = "Clinical pharmacology of ticarcillin in the newborn infant: Relation to age, gestational age, and weight",
abstract = "Ticarcillin, a new penicillin derivative with greater in vitro activity against Pseudomonas than carbenicillin, was given as a single dose of 50 mg/kg intramuscularly on 61 occasions to 54 neonates and young infants. The serum concentrations and rate of elimination varied considerably depending upon gestational age, chronological age, and body weight. Peak serum concentrations depended principally upon the volume of distribution which approximated the extracellular fluid volume of the neonate. The plasma clearance and serum half-life of the drug were determined. From these pharmacokinetic data appropriate groupings according to age and body weight were made and dosages and intervals of administration predicted for clinical trials of efficacy with repeated doses.",
author = "Nelson, {John D.} and Sharon Shelton and Helen Kusmiesz",
year = "1975",
doi = "10.1016/S0022-3476(75)80664-0",
language = "English (US)",
volume = "87",
pages = "474--479",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Clinical pharmacology of ticarcillin in the newborn infant

T2 - Relation to age, gestational age, and weight

AU - Nelson, John D.

AU - Shelton, Sharon

AU - Kusmiesz, Helen

PY - 1975

Y1 - 1975

N2 - Ticarcillin, a new penicillin derivative with greater in vitro activity against Pseudomonas than carbenicillin, was given as a single dose of 50 mg/kg intramuscularly on 61 occasions to 54 neonates and young infants. The serum concentrations and rate of elimination varied considerably depending upon gestational age, chronological age, and body weight. Peak serum concentrations depended principally upon the volume of distribution which approximated the extracellular fluid volume of the neonate. The plasma clearance and serum half-life of the drug were determined. From these pharmacokinetic data appropriate groupings according to age and body weight were made and dosages and intervals of administration predicted for clinical trials of efficacy with repeated doses.

AB - Ticarcillin, a new penicillin derivative with greater in vitro activity against Pseudomonas than carbenicillin, was given as a single dose of 50 mg/kg intramuscularly on 61 occasions to 54 neonates and young infants. The serum concentrations and rate of elimination varied considerably depending upon gestational age, chronological age, and body weight. Peak serum concentrations depended principally upon the volume of distribution which approximated the extracellular fluid volume of the neonate. The plasma clearance and serum half-life of the drug were determined. From these pharmacokinetic data appropriate groupings according to age and body weight were made and dosages and intervals of administration predicted for clinical trials of efficacy with repeated doses.

UR - http://www.scopus.com/inward/record.url?scp=0016754650&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016754650&partnerID=8YFLogxK

U2 - 10.1016/S0022-3476(75)80664-0

DO - 10.1016/S0022-3476(75)80664-0

M3 - Article

C2 - 1165530

AN - SCOPUS:0016754650

VL - 87

SP - 474

EP - 479

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 3

ER -